Akshay G. Patel, MS, MD, PhD
Hospital ResidentCards
About
Research
Publications
2024
Redox Pathogenesis in Rheumatic Diseases.
Laniak OT, Winans T, Patel A, Park J, Perl A. Redox Pathogenesis in Rheumatic Diseases. ACR Open Rheumatol 2024, 6: 334-346. PMID: 38664977, DOI: 10.1002/acr2.11668.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsRab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation.
Huang N, Winans T, Wyman B, Oaks Z, Faludi T, Choudhary G, Lai ZW, Lewis J, Beckford M, Duarte M, Krakko D, Patel A, Park J, Caza T, Sadeghzadeh M, Morel L, Haas M, Middleton F, Banki K, Perl A. Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation. Nat Commun 2024, 15: 2598. PMID: 38519468, DOI: 10.1038/s41467-024-46441-2.Peer-Reviewed Original Research
2023
mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency.
Winans T, Oaks Z, Choudhary G, Patel A, Huang N, Faludi T, Krakko D, Nolan J, Lewis J, Blair S, Lai Z, Landas SK, Middleton F, Asara JM, Chung SK, Wyman B, Azadi P, Banki K, Perl A. mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency. J Autoimmun 2023, 140: 103112. PMID: 37742509, DOI: 10.1016/j.jaut.2023.103112.Peer-Reviewed Original ResearchPublisher Correction: Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis.
Oaks Z, Patel A, Huang N, Choudhary G, Winans T, Faludi T, Krakko D, Duarte M, Lewis J, Beckford M, Blair S, Kelly R, Landas SK, Middleton FA, Asara JM, Chung SK, Fernandez DR, Banki K, Perl A. Publisher Correction: Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis. Nat Metab 2023, 5: 349. PMID: 36755183, DOI: 10.1038/s42255-023-00752-8.Peer-Reviewed Original ResearchLy-6A-Induced Growth Inhibition and Cell Death in a Transformed CD4(+) T Cell Line: Role of Tumor Necrosis Factor-α.
Patel AG, Moxham S, Bamezai AK. Ly-6A-Induced Growth Inhibition and Cell Death in a Transformed CD4(+) T Cell Line: Role of Tumor Necrosis Factor-α. Arch Immunol Ther Exp (Warsz) 2023, 71: 4. PMID: 36725744, DOI: 10.1007/s00005-023-00670-3.Peer-Reviewed Original ResearchCytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis.
Oaks Z, Patel A, Huang N, Choudhary G, Winans T, Faludi T, Krakko D, Duarte M, Lewis J, Beckford M, Blair S, Kelly R, Landas SK, Middleton FA, Asara JM, Chung SK, Fernandez DR, Banki K, Perl A. Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis. Nat Metab 2023, 5: 41-60. PMID: 36658399, DOI: 10.1038/s42255-022-00711-9.Peer-Reviewed Original Research
2022
Redox Control of Integrin-Mediated Hepatic Inflammation in Systemic Autoimmunity.
Patel A, Perl A. Redox Control of Integrin-Mediated Hepatic Inflammation in Systemic Autoimmunity. Antioxid Redox Signal 2022, 36: 367-388. PMID: 34036799, DOI: 10.1089/ars.2021.0068.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2017
Engaging Ly-6A/Sca-1 triggers lipid raft-dependent and -independent responses in CD4(+) T-cell lines.
Lang MA, Jenkins SA, Balzano P, Owoyele A, Patel A, Bamezai AK. Engaging Ly-6A/Sca-1 triggers lipid raft-dependent and -independent responses in CD4(+) T-cell lines. Immun Inflamm Dis 2017, 5: 448-460. PMID: 28660664, DOI: 10.1002/iid3.182.Peer-Reviewed Original Research